Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Using corticosteroids to improve swallowing in patients with laryngeal edema after respiratory failure

Official title: Randomized Trial of Corticosteroids for Post-Extubation Aspiration

Run by University of Colorado, Denver · NCT06670521 · Data updated 2026-11-12

This study is testing whether giving corticosteroids can help people who have trouble swallowing due to swelling in their throat after recovering from respiratory failure.

More Dysphagia trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Drugs / interventionsPrednisone
Locations1 site (Aurora, Colorado)
StatusRecruiting
StartedDecember 2, 2024
Main results expectedNovember 30, 2026
Study endsMay 31, 2027
Registry record updatedMay 6, 2026
Trial IDNCT06670521 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are survivors of acute respiratory failure with documented laryngeal edema who have been enrolled in a related longitudinal study.

Probably not a fit

Patients with pre-existing dysphagia, neuromuscular disorders, or contraindications to corticosteroids may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter trial investigates the effects of intravenous corticosteroids on laryngeal edema and swallowing function in survivors of acute respiratory failure who have documented laryngeal edema. A total of 80 participants will be enrolled across four sites: University of Colorado, Boston University, Stanford University, and Yale University. Participants will be randomized into two groups, with one receiving corticosteroids and the other a saline placebo. The study aims to measure the reduction in laryngeal edema and evaluate improvements in swallowing function and quality of life after treatment.

Why it matters

Potential benefit: If successful, this treatment could significantly improve swallowing function and quality of life for patients recovering from acute respiratory failure.

How similar studies have gone: While this approach is novel in this specific context, similar studies have shown promise in using corticosteroids for reducing edema in other conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participant enrolled in primary study COMIRB #21-3873/ NCT # 05108896
* Laryngeal edema identified on participants primary study Fiberoptic Endoscopic Evaluation of Swallowing (FEES) as defined as a revised Patterson edema score greater than zero
* Admission to an ICU during their hospitalization
* Mechanical ventilation with an endotracheal tube for greater than 48 hours.
* Extubation except for compassionate extubation or transition to end-of-life care.

Exclusion Criteria:

* Patient or provider refusal
* Contraindication or corticosteroids defined as an allergic reaction (extremely rate) or taking other immunosuppressive medications.
* Chronic treatment with corticosteroids (\>= 40 mg Prednisone/day, \>=32 Methylprednisolone/day)
* Contraindication to enteral/oral nutrition administration.
* Pre-existing history of dysphagia or aspiration.
* Pre-existing or acute primary central or peripheral neuromuscular disorder.
* Presence of a chronic tracheostomy (present prior to ICU admission).
* Pre-existing head and neck cancer or surgery.
* Coagulopathy resulting in uncontrolled nasal or pharyngeal bleeding.
* Delirium as assessed by CAM-ICU
* Inability to obtain informed consent from patient or an appropriate surrogate.
* Age \<18 years.

Where it's running

  • University of Colorado
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.